688658 悦康药业
已收盘 05-09 15:00:00
资讯
新帖
简况
从质量升级到创新突围,悦康药业开启生物医药发展新范式
IT新闻网 · 05-04
从质量升级到创新突围,悦康药业开启生物医药发展新范式
悦康药业创新引擎驱动,开启医药高质量发展新征程
iDoNews · 04-30
悦康药业创新引擎驱动,开启医药高质量发展新征程
悦康药业(688658)2025年一季报简析:净利润减171.09%
证券之星 · 04-29
悦康药业(688658)2025年一季报简析:净利润减171.09%
悦康药业构建mRNA技术生态,加速生物医药创新步伐
全景网 · 04-29
悦康药业构建mRNA技术生态,加速生物医药创新步伐
悦康药业截止03月31日股东人数1.47万户,人均持股3.05万股
市场透视 · 04-29
悦康药业截止03月31日股东人数1.47万户,人均持股3.05万股
悦康药业跌5% 3券商曾建议买入
智选洞察 · 04-29
悦康药业跌5% 3券商曾建议买入
悦康药业一季度亏损4927万元 同比降171.1%
财中社 · 04-28
悦康药业一季度亏损4927万元 同比降171.1%
悦康药业:注射用更昔洛韦通过仿制药一致性评价
南方财经网 · 04-28
悦康药业:注射用更昔洛韦通过仿制药一致性评价
悦康药业控股股东2650万股因合作纠纷将被司法拍卖
财中社 · 04-28
悦康药业控股股东2650万股因合作纠纷将被司法拍卖
悦康药业:控股股东本次被冻结1519万股
每日经济新闻 · 04-27
悦康药业:控股股东本次被冻结1519万股
AI制药管线数量快速提升!上百个AI驱动的药物管线获批临床
制药网 · 04-24
AI制药管线数量快速提升!上百个AI驱动的药物管线获批临床
AACR即将开幕,医药或迎密集催化
Ofweek维科网 · 04-24
AACR即将开幕,医药或迎密集催化
悦康药业04月23日遭主力抛售50万元
市场透视 · 04-23
悦康药业04月23日遭主力抛售50万元
每周股票复盘:悦康药业(688658)因收盘价格涨幅达15%首登龙虎榜
证券之星 · 04-18
每周股票复盘:悦康药业(688658)因收盘价格涨幅达15%首登龙虎榜
龙虎榜 | 消闲派、T王抢筹9天7板中旗新材,涪陵广场路撤离湖南黄金超1.4亿
格隆汇 · 04-14
龙虎榜 | 消闲派、T王抢筹9天7板中旗新材,涪陵广场路撤离湖南黄金超1.4亿
【科创板收评】午后盘面震荡回落,科创50收涨0.25%,医药板块反复活跃
犀牛之星 · 04-14
【科创板收评】午后盘面震荡回落,科创50收涨0.25%,医药板块反复活跃
【A股午评:创业板指半日涨0.82% 全市场超4800只个股上涨】A股三大指数今日集体上涨,截至午盘,沪指涨0.86%,深成指涨0.91%,创业板指涨0.82%,北证50指数涨2.33%。全市场半日成交额8621亿元,较上日放量648亿元。全市场超4800只个股上涨。板块题材上,海南自贸区、互联网电商、露营经济、零售板块涨幅居前;转基因、白酒板块跌幅居前。盘面上,跨境电商板块掀涨停潮,三态股份、生意宝、南极电商、龙头股份、跨境通、中源家居等多股涨停。海南本地股领涨,康芝药业、海马汽车、京粮控股、海汽集团、海南海药涨停。大消费方向反复活跃,国芳集团7连板,岭南控股、茂业商业、南宁百货、绝味食品、三江购物涨停。创新药概念活跃,一品红、悦康药业、葫芦娃涨停。
金融界 · 04-14
【A股午评:创业板指半日涨0.82% 全市场超4800只个股上涨】A股三大指数今日集体上涨,截至午盘,沪指涨0.86%,深成指涨0.91%,创业板指涨0.82%,北证50指数涨2.33%。全市场半日成交额8621亿元,较上日放量648亿元。全市场超4800只个股上涨。板块题材上,海南自贸区、互联网电商、露营经济、零售板块涨幅居前;转基因、白酒板块跌幅居前。盘面上,跨境电商板块掀涨停潮,三态股份、生意宝、南极电商、龙头股份、跨境通、中源家居等多股涨停。海南本地股领涨,康芝药业、海马汽车、京粮控股、海汽集团、海南海药涨停。大消费方向反复活跃,国芳集团7连板,岭南控股、茂业商业、南宁百货、绝味食品、三江购物涨停。创新药概念活跃,一品红、悦康药业、葫芦娃涨停。
异动快报:悦康药业(688658)4月14日11点2分触及涨停板
证券之星 · 04-14
异动快报:悦康药业(688658)4月14日11点2分触及涨停板
科创医药指数ETF涨逾1.5%,悦康药业涨超19%,机构:看好2025年医药行业的投资机会
21世纪经济报道 · 04-14
科创医药指数ETF涨逾1.5%,悦康药业涨超19%,机构:看好2025年医药行业的投资机会
A股化学制药板块走高,一品红、悦康药业涨超10%,哈三联、奥赛康、益方生物、海创药业、盟科药业等跟涨。
美港电讯 · 04-14
A股化学制药板块走高,一品红、悦康药业涨超10%,哈三联、奥赛康、益方生物、海创药业、盟科药业等跟涨。
公司概况
公司名称:
悦康药业集团股份有限公司
所属行业:
医药制造业
上市日期:
2020-12-24
主营业务:
悦康药业集团股份有限公司的主营业务涵盖药品研发,制造,流通销售全产业链条,具备原料,辅料,制剂全产业链的生产能力;产品适应症包括心脑血管,糖尿病,消化系统,抗肿瘤,抗病毒,生殖健康等多个治疗领域,聚焦慢病以及专科治疗领域;产品类型涵盖化药,中药两大类型;产品剂型涵盖注射剂,冻干粉针剂,片剂,胶囊剂等多种剂型。公司实力雄厚,连续多年入选工信部医药工业百强和中国医药研发产品线最佳工业企业。公司“奥美拉唑系列产品产业化与国际化的关键技术开发项目”、“化学药物晶型关键技术体系的建立与应用”先后获得国家科学技术进步二等奖。
发行价格:
24.36
{"stockData":{"symbol":"688658","market":"SH","secType":"STK","nameCN":"悦康药业","latestPrice":15.23,"timestamp":1746774000000,"preClose":15.91,"halted":0,"volume":8681204,"delay":0,"changeRate":-0.0427,"floatShares":450000000,"shares":450000000,"eps":0.0115,"marketStatus":"已收盘","change":-0.68,"latestTime":"05-09 15:00:00","open":15.87,"high":16.04,"low":15.15,"amount":134000000,"amplitude":0.0559,"askPrice":15.26,"askSize":2,"bidPrice":15.23,"bidSize":14,"shortable":0,"etf":0,"ttmEps":0.0115,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1747013400000},"marketStatusCode":5,"adr":0,"adjPreClose":15.91,"symbolType":"stock_kcb","openAndCloseTimeList":[[1746754200000,1746761400000],[1746766800000,1746774000000]],"highLimit":17.5,"lowLimit":14.32,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":450000000,"isCdr":false,"pbRate":1.94,"roa":"--","peRate":1324.347826,"roe":"--","epsLYR":0.28,"committee":-0.119675,"marketValue":6854000000,"turnoverRate":0.0193,"status":1,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2025-05-12。","afterMarket":{"amount":0,"volume":0,"close":15.23,"buyVolume":0,"sellVolume":0,"time":1746776038029,"indexStatus":"已收盘 05-09 15:30:00","preClose":15.91},"floatMarketCap":6854000000},"requestUrl":"/m/hq/s/688658/wiki","defaultTab":"wiki","newsList":[{"id":"2532931337","title":"从质量升级到创新突围,悦康药业开启生物医药发展新范式","url":"https://stock-news.laohu8.com/highlight/detail?id=2532931337","media":"IT新闻网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532931337?lang=zh_cn&edition=full","pubTime":"2025-05-04 15:01","pubTimestamp":1746342064,"startTime":"0","endTime":"0","summary":"质量始终是悦康药业发展的生命线。创新研发则为悦康药业开辟了全新增长曲线。目前,悦康药业在AI药物研发领域已斩获10余项授权专利,并在国际知名期刊发表2篇研究论文。从质量筑基到创新突破,再到数字赋能,悦康药业构建起\"质量打底、创新驱动、数字支撑\"的复合型发展体系。展望未来,凭借独特的竞争优势,悦康药业有望在全球生物医药市场中持续突破,为行业高质量发展注入新的活力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050416001994ec0d9a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050416001994ec0d9a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["161726","399441","BK0239","688658"],"gpt_icon":0},{"id":"2531411728","title":"悦康药业创新引擎驱动,开启医药高质量发展新征程","url":"https://stock-news.laohu8.com/highlight/detail?id=2531411728","media":"iDoNews","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531411728?lang=zh_cn&edition=full","pubTime":"2025-04-30 10:08","pubTimestamp":1745978889,"startTime":"0","endTime":"0","summary":"面对AI重塑医疗行业格局的趋势,悦康药业率先布局,打造全流程AI药物研发平台。未来,悦康药业将继续以创新为笔,在医药领域书写高质量发展的崭新篇章,向着成为全球医药创新领军企业的目标奋勇前行。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025043010115994e84651&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025043010115994e84651&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688658","159938","399050","BK0239"],"gpt_icon":0},{"id":"2531593711","title":"悦康药业(688658)2025年一季报简析:净利润减171.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531593711","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531593711?lang=zh_cn&edition=full","pubTime":"2025-04-30 06:43","pubTimestamp":1745966605,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期悦康药业发布2025年一季报。根据财报显示,悦康药业净利润减171.09%。截至本报告期末,公司营业总收入5.77亿元,同比下降40.35%,归母净利润-4927.11万元,同比下降171.09%。财报体检工具显示:建议关注公司应收账款状况持有悦康药业最多的基金为南方医药保健灵活配置混合A,目前规模为21.83亿元,最新净值2.0946,较上一交易日上涨0.39%,近一年下跌0.03%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025043000008025.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688658"],"gpt_icon":0},{"id":"2531786573","title":"悦康药业构建mRNA技术生态,加速生物医药创新步伐","url":"https://stock-news.laohu8.com/highlight/detail?id=2531786573","media":"全景网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531786573?lang=zh_cn&edition=full","pubTime":"2025-04-29 18:20","pubTimestamp":1745922000,"startTime":"0","endTime":"0","summary":"近日,医药行业传来喜讯,悦康药业在新药研发领域再获突破。此前,该疫苗已获美国FDA临床试验批准,这一成果标志着悦康药业在mRNA疫苗研发赛道上稳步前行,展现出强劲的创新实力与国际竞争力。值得一提的是,悦康药业自主创新的核酸递送系统获得美国、日本、以色列等多国专利授权,这一重大技术突破,为其mRNA疫苗及核酸药物研发奠定了坚实基础。悦康药业董事、药物研究院院长宋更申介绍,公司建立了独特的mRNA技术生态。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042918212294e76008&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042918212294e76008&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688658","161726","399441"],"gpt_icon":0},{"id":"2531037112","title":"悦康药业截止03月31日股东人数1.47万户,人均持股3.05万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2531037112","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531037112?lang=zh_cn&edition=full","pubTime":"2025-04-29 15:59","pubTimestamp":1745913552,"startTime":"0","endTime":"0","summary":"悦康药业披露公司股东人数最新情况,截止2025年03月31日,公司股东人数为1.47万户,较上期增加342户,环比增长2.5%。人均持仓股环比下降情形用户持仓来看,悦康药业人均持仓3.05万股,上期人均持仓3.13万股,环比减少2.56%,户均持股趋向分散。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429165725a46bcc95&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429165725a46bcc95&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688658","BK0239"],"gpt_icon":0},{"id":"2531085215","title":"悦康药业跌5% 3券商曾建议买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2531085215","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531085215?lang=zh_cn&edition=full","pubTime":"2025-04-29 09:30","pubTimestamp":1745890253,"startTime":"0","endTime":"0","summary":"04月29日,悦康药业股价大幅下跌,截至09点30分,悦康药业下跌5.05%,报14.48元/股,成交1504万元,换手率0.23%,振幅3.41%。资金动向截止发稿,悦康药业获得主力净流出99万元,其中超大单流出20万元,大单流出77万元。主营业务及业绩悦康药业公司主营业务为悦康药业定位于高端化学药的研发与生产,报告期内主营业务收入主要集中在心脑血管药物、消化系统药物、糖尿病用药以及抗感染药物等。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429093339a6cc7226&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429093339a6cc7226&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688658","BK0239"],"gpt_icon":0},{"id":"2530605405","title":"悦康药业一季度亏损4927万元 同比降171.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530605405","media":"财中社","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530605405?lang=zh_cn&edition=full","pubTime":"2025-04-28 19:22","pubTimestamp":1745839334,"startTime":"0","endTime":"0","summary":"4月28日,悦康药业公布2025年一季报,公司营业收入为5.77亿元,同比下降40.3%;归母净利润亏损4927万元,同比下降171.1%;扣非归母净利润亏损5347万元,同比下降182.7%;经营现金流净额为8104万元,同比下降44.5%;EPS为-0.1095元。截至一季度末,公司总资产56.11亿元,较上年度末下降2.2%;归母净资产为35.28亿元,较上年度末下降1.4%。本期研发投入占营业收入的比例为17.19%,较上年同期增加了7.16个百分点,显示出公司在创新方面的持续努力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042819231194e5ca5e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042819231194e5ca5e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688658"],"gpt_icon":0},{"id":"2530875472","title":"悦康药业:注射用更昔洛韦通过仿制药一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2530875472","media":"南方财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530875472?lang=zh_cn&edition=full","pubTime":"2025-04-28 18:20","pubTimestamp":1745835652,"startTime":"0","endTime":"0","summary":"南方财经4月28日电,悦康药业公告称,公司收到国家药品监督管理局核准签发的关于注射用更昔洛韦(规格:0.5g)的《药品补充申请批准通知书》,该药品通过仿制药质量和疗效一致性评价。注射用更昔洛韦主要用于治疗危及生命或视觉的免疫缺陷患者的巨细胞病毒感染,以及预防器官移植病人的巨细胞病毒感染。此次获批有利于扩大公司产品的市场份额,提升市场竞争力。文章来源:南方财经网原标题:悦康药业:注射用更昔洛韦通过仿制药一致性评价","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428185943a46a5178&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428185943a46a5178&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688658","BK0239"],"gpt_icon":0},{"id":"2530496727","title":"悦康药业控股股东2650万股因合作纠纷将被司法拍卖","url":"https://stock-news.laohu8.com/highlight/detail?id=2530496727","media":"财中社","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530496727?lang=zh_cn&edition=full","pubTime":"2025-04-28 09:29","pubTimestamp":1745803796,"startTime":"0","endTime":"0","summary":"4月27日,悦康药业(688658)发布公告,控股股东阜阳京悦永顺信息咨询有限公司(以下简称“公司”)持有的2650万股无限售流通股将被司法拍卖。该股份占公司总股本的5.88%。此次拍卖是由于京悦永顺与宁波惟精昫竔股权投资合伙企业、宁波焓湜枫德股权投资合伙企业之间的纠纷,经过仲裁后,北京二中院作出执行裁决并立案强制执行。本次拍卖将在北京市第二中级人民法院的网络平台进行,起拍价为13.43元/股,保证金为1.34元/股。截至公告日,京悦永顺共持有公司股份1.8亿股,占公司总股本的比例为40.05%。2024年,悦康药业实现收入37.81亿元,归母净利润1.24亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504280930189747cdbb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504280930189747cdbb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688658","BK0239"],"gpt_icon":0},{"id":"2530670456","title":"悦康药业:控股股东本次被冻结1519万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2530670456","media":"每日经济新闻","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530670456?lang=zh_cn&edition=full","pubTime":"2025-04-27 22:40","pubTimestamp":1745764829,"startTime":"0","endTime":"0","summary":"每经AI快讯,悦康药业(SH 688658,收盘价:17.17元)4月27日晚间发布公告称,悦康药业集团股份有限公司(以下简称“公司”)控股股东阜阳京悦永顺信息咨询有限公司(以下简称“京悦永顺”)持有公司180,240,120股,占公司总股本的比例为40.05%。本次冻结数量为15,196,002股,占其所持股份比例的8.43%,占公司总股本比例3.38%。截至发稿,悦康药业市值为77亿元。每经头条(nbdtoutiao)——这款“神药”一年卖出2100亿元,连续两年称霸全球,多家中国公司却在新药上市前壮士断腕,有公司不惜计提上亿元损失也要坚决出局(记者 曾健辉)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042722405394e4c8c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042722405394e4c8c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688658","BK0239"],"gpt_icon":0},{"id":"2529793817","title":"AI制药管线数量快速提升!上百个AI驱动的药物管线获批临床","url":"https://stock-news.laohu8.com/highlight/detail?id=2529793817","media":"制药网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529793817?lang=zh_cn&edition=full","pubTime":"2025-04-24 14:57","pubTimestamp":1745477831,"startTime":"0","endTime":"0","summary":"自 AI 技术开始应用于药物研发以来,AI 驱动的药物管线数量呈现出爆发式增长。如今,全球范围内已有 102 个 AI 驱动的药物管线获批临床试验,其中56个处于Ⅰ期、41个处于Ⅱ期、5个处于Ⅲ期,涵盖了多种疾病领域,包括肿瘤、神经系统疾病、心血管疾病等。一些用于治疗心律失常、心力衰竭等心血管疾病的 AI 驱动药物管线,正在临床试验中接受进一步验证,有望为心血管疾病患者提供更有效的治疗方案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042414581494e09c56&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042414581494e09c56&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600488","600267","603676","688566","600216","603538","BK0046","601089","600812","BK0239","603669","688658","688578","600521","605116","688799","605507","600062","688076","600380","600420","BK0168","600851","600789","603351","688117","BK0188","603367"],"gpt_icon":0},{"id":"2529462576","title":"AACR即将开幕,医药或迎密集催化","url":"https://stock-news.laohu8.com/highlight/detail?id=2529462576","media":"Ofweek维科网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529462576?lang=zh_cn&edition=full","pubTime":"2025-04-24 11:19","pubTimestamp":1745464762,"startTime":"0","endTime":"0","summary":"AACR将于当地时间4月25日至4月30日在美国费城召开,本次会议将有近100家中国药企亮相,带来超200项新药研究结果。恒瑞医药、科伦博泰、信达生物、百利天恒、再鼎医药、复宏汉霖、乐普生物等有望发布重要ADC数据,涉及诸多靶点,中国ADC技术有望在国际舞台崭露头角。近年来,国内创新药在AACR会议上的影响力持续攀升,ADC之外,双抗及小分子疗法市场关注度也较高,或带来更多消息面的催化,恒生医药ETF已连续5日上涨。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504241119259742f8a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504241119259742f8a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0028","603367","BK0012","600196","688506","600664","605507","600216","603669","BK0175","605116","BK0187","688091","688799","600267","600521","603676","BK0239","688247","688166","600488","600420","688076","688566","688578","600062","BK0096","BK0060","601089","BK0196","159938","BK0188","600789","688505","688602","600812","603351","600380","603538","BK0183","688658"],"gpt_icon":0},{"id":"2529571145","title":"悦康药业04月23日遭主力抛售50万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529571145","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529571145?lang=zh_cn&edition=full","pubTime":"2025-04-23 15:22","pubTimestamp":1745392970,"startTime":"0","endTime":"0","summary":"04月23日, 悦康药业股价跌2.39%,报收15.94元,成交金额1.80亿元,换手率2.50%,振幅5.02%,量比0.92。悦康药业今日主力资金净流出50万元,连续7日净流出,上一交易日主力净流出856万元。|04月23日主力加仓幅度排名||#|股票简称|主力净额占比|#|健尔康|8.43%|#|新天地|7.95%|#|利安科技|7.56%|#|...|...|#2538|悦康药业|-0.01%|悦康药业所在的化学制药行业,今日主力净流出1.78亿元,行业排名28/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423165033a463a696&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423165033a463a696&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688658","BK0239"],"gpt_icon":0},{"id":"2528013466","title":"每周股票复盘:悦康药业(688658)因收盘价格涨幅达15%首登龙虎榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2528013466","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528013466?lang=zh_cn&edition=full","pubTime":"2025-04-19 03:11","pubTimestamp":1745003487,"startTime":"0","endTime":"0","summary":"截至2025年4月18日收盘,悦康药业报收于16.34元,较上周的13.46元上涨21.4%。本周,悦康药业4月16日盘中最高价报16.95元。悦康药业当前最新总市值73.53亿元,在化学制药板块市值排名60/152,在两市A股市值排名1967/5146。本周关注点交易信息汇总:悦康药业因收盘价格涨幅达到15%首次登上龙虎榜交易信息汇总沪深交易所2025年4月14日公布的交易公开信息显示,悦康药业因有价格涨跌幅限制的日收盘价格涨幅达到15%的前五只证券登上龙虎榜。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025041900004745.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688658","BK0239"],"gpt_icon":0},{"id":"2527134634","title":"龙虎榜 | 消闲派、T王抢筹9天7板中旗新材,涪陵广场路撤离湖南黄金超1.4亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2527134634","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527134634?lang=zh_cn&edition=full","pubTime":"2025-04-14 18:20","pubTimestamp":1744626034,"startTime":"0","endTime":"0","summary":"今日龙虎榜净买入额前三为湖南黄金、天和磁材、悦康药业","market":"sg","thumbnail":"https://img3.gelonghui.com/35d7c-d2e9992d-15ef-4f42-b75a-1ee12b611dd4.jpg?guru_height=852&guru_width=1280","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/35d7c-d2e9992d-15ef-4f42-b75a-1ee12b611dd4.jpg?guru_height=852&guru_width=1280"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/2040662","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK0214","BK0039","BK0004","BK0238","BK0182","688658","BK0242","002165","603072","BK0070","BK0086","600697","002286","BK0229","002155","BK0239","BK0138","BK0209","BK0028","BK0127","BK0050","BK0057"],"gpt_icon":0},{"id":"2527086909","title":"【科创板收评】午后盘面震荡回落,科创50收涨0.25%,医药板块反复活跃","url":"https://stock-news.laohu8.com/highlight/detail?id=2527086909","media":"犀牛之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527086909?lang=zh_cn&edition=full","pubTime":"2025-04-14 15:15","pubTimestamp":1744614900,"startTime":"0","endTime":"0","summary":"犀牛之星4月14日讯,今日科创板整体冲高回落,指数早间震荡拉升,午后小幅震荡回落涨幅收窄,科创50收涨0.25%,报1014.28点。截至当日收市,共402只个股收涨,176只个股收跌。涨幅排行方面,悦康药业涨19.99%居首,科兴制药涨16.83%次之。跌幅排行方面,ST观典 跌9.24%居首,唯捷创芯 跌5.33%次之。成交额方面,科创板全天共成交1040.61亿元,寒武纪 成交55.42居首,中芯国际 成交34.78亿元次之。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041415172494d4b5c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041415172494d4b5c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["159938","000688","688136","000688.SH","BK0242","159982","688658"],"gpt_icon":0},{"id":"2527929619","title":"【A股午评:创业板指半日涨0.82% 全市场超4800只个股上涨】A股三大指数今日集体上涨,截至午盘,沪指涨0.86%,深成指涨0.91%,创业板指涨0.82%,北证50指数涨2.33%。全市场半日成交额8621亿元,较上日放量648亿元。全市场超4800只个股上涨。板块题材上,海南自贸区、互联网电商、露营经济、零售板块涨幅居前;转基因、白酒板块跌幅居前。盘面上,跨境电商板块掀涨停潮,三态股份、生意宝、南极电商、龙头股份、跨境通、中源家居等多股涨停。海南本地股领涨,康芝药业、海马汽车、京粮控股、海汽集团、海南海药涨停。大消费方向反复活跃,国芳集团7连板,岭南控股、茂业商业、南宁百货、绝味食品、三江购物涨停。创新药概念活跃,一品红、悦康药业、葫芦娃涨停。","url":"https://stock-news.laohu8.com/highlight/detail?id=2527929619","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527929619?lang=zh_cn&edition=full","pubTime":"2025-04-14 11:39","pubTimestamp":1744601994,"startTime":"0","endTime":"0","summary":"A股三大指数今日集体上涨,截至午盘,沪指涨0.86%,深成指涨0.91%,创业板指涨0.82%,北证50指数涨2.33%。全市场半日成交额8621亿元,较上日放量648亿元。全市场超4800只个股上涨。板块题材上,海南自贸区、互联网电商、露营经济、零售板块涨幅居前;转基因、白酒板块跌幅居前。盘面上,跨境电商板块掀涨停潮,三态股份、生意宝、南极电商、龙头股份、跨境通、中源家居等多股涨停。海南本地股领涨,康芝药业、海马汽车、京粮控股、海汽集团、海南海药涨停。大消费方向反复活跃,国芳集团7连板,岭南控股、茂业商业、南宁百货、绝味食品、三江购物涨停。创新药概念活跃,一品红、悦康药业、葫芦娃涨停。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/14113949515220.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0063","601086","600712","159792","000997.SH","160636","002095","159982","BK0065","000572","159992","BK0173","601116","301558","BK0253","002127","300086","BK0260","603709","BK0028","688658","BK0238","603517","000505","BK0042","000524","BK0170","605199","BK0174","BK0247","BK0264","06978","600630","399006","BK0060","BK0055","BK0186","BK0209","399300","BK0164","603069","002640","000566","300723","BK0095","600828","BK0217","BK0239","BK0196"],"gpt_icon":0},{"id":"2527928057","title":"异动快报:悦康药业(688658)4月14日11点2分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2527928057","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527928057?lang=zh_cn&edition=full","pubTime":"2025-04-14 11:05","pubTimestamp":1744599919,"startTime":"0","endTime":"0","summary":"证券之星4月14日盘中消息,11点2分悦康药业触及涨停板。目前价格16.15,上涨19.99%。其所属行业化学制药目前上涨。领涨股为一品红。该股为创新药,医药,中药概念热股,当日创新药概念上涨3.29%,医药概念上涨2.75%,中药概念上涨2.7%。4月11日的资金流向数据方面,主力资金净流出550.79万元,占总成交额5.63%,游资资金净流入1011.63万元,占总成交额10.34%,散户资金净流出460.85万元,占总成交额4.71%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025041400008438.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688658","BK0239"],"gpt_icon":0},{"id":"2527926042","title":"科创医药指数ETF涨逾1.5%,悦康药业涨超19%,机构:看好2025年医药行业的投资机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2527926042","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527926042?lang=zh_cn&edition=full","pubTime":"2025-04-14 11:03","pubTimestamp":1744599829,"startTime":"0","endTime":"0","summary":"4月14日,A股三大指数集体上涨,上证科创板生物医药指数上涨1.37%;该指数成分股中,悦康药业上涨超19%,智翔金泰上涨超9%,三生国健上涨超6%。相关ETF方面,科创医药指数ETF截至发稿上涨超1.5%,涨跌幅暂居同标的产品第1名。该ETF最新流通份额为3.65亿份,最新流通规模为3.49亿元。中信建投表示,继续看好2025年医药行业的投资机会。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504141123049737092f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504141123049737092f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["588700","BK0239","688658"],"gpt_icon":0},{"id":"2527594614","title":"A股化学制药板块走高,一品红、悦康药业涨超10%,哈三联、奥赛康、益方生物、海创药业、盟科药业等跟涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2527594614","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527594614?lang=zh_cn&edition=full","pubTime":"2025-04-14 09:56","pubTimestamp":1744595818,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["159982","BK0028","688658","399300","688302","002755","BK1191","688373","300723","BK1574","002900","01477","BK0239","688382"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1746867895871,"stockEarnings":[{"period":"1week","weight":-0.077},{"period":"1month","weight":0.1761},{"period":"3month","weight":0.0106},{"period":"6month","weight":-0.3228},{"period":"1year","weight":-0.1155},{"period":"ytd","weight":0.0569}],"compareEarnings":[{"period":"1week","weight":0.0192},{"period":"1month","weight":0.0487},{"period":"3month","weight":0.0116},{"period":"6month","weight":-0.0319},{"period":"1year","weight":0.0595},{"period":"ytd","weight":-0.0029}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"悦康药业集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"14742人(较上一季度增加2.50%)","perCapita":"30525股","listingDate":"2020-12-24","address":"北京市大兴区北京经济技术开发区宏达中路6号","registeredCapital":"45000万元","survey":" 悦康药业集团股份有限公司的主营业务涵盖药品研发,制造,流通销售全产业链条,具备原料,辅料,制剂全产业链的生产能力;产品适应症包括心脑血管,糖尿病,消化系统,抗肿瘤,抗病毒,生殖健康等多个治疗领域,聚焦慢病以及专科治疗领域;产品类型涵盖化药,中药两大类型;产品剂型涵盖注射剂,冻干粉针剂,片剂,胶囊剂等多种剂型。公司实力雄厚,连续多年入选工信部医药工业百强和中国医药研发产品线最佳工业企业。公司“奥美拉唑系列产品产业化与国际化的关键技术开发项目”、“化学药物晶型关键技术体系的建立与应用”先后获得国家科学技术进步二等奖。","listedPrice":24.36},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.4","shortVersion":"4.33.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"悦康药业(688658)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供悦康药业(688658)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"悦康药业,688658,悦康药业股票,悦康药业股票老虎,悦康药业股票老虎国际,悦康药业行情,悦康药业股票行情,悦康药业股价,悦康药业股市,悦康药业股票价格,悦康药业股票交易,悦康药业股票购买,悦康药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"悦康药业(688658)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供悦康药业(688658)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}